Back to Search
Start Over
Chronic 5-HT 2 receptor blockade unmasks the role of 5-HT 1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow.
- Source :
-
Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2018 Apr; Vol. 96 (4), pp. 328-336. Date of Electronic Publication: 2017 Sep 08. - Publication Year :
- 2018
-
Abstract
- Serotonin (5-hydroxytryptamine; 5-HT) inhibits the rat cardioaccelerator sympathetic outflow by 5-HT <subscript>1B/1D/5</subscript> receptors. Because chronic blockade of sympatho-excitatory 5-HT <subscript>2</subscript> receptors is beneficial in several cardiovascular pathologies, this study investigated whether sarpogrelate (a 5-HT <subscript>2</subscript> receptor antagonist) alters the pharmacological profile of the above sympatho-inhibition. Rats were pretreated for 2 weeks with sarpogrelate in drinking water (30 mg/kg per day; sarpogrelate-treated group) or equivalent volumes of drinking water (control group). Animals were pithed and prepared for spinal stimulation (C <subscript>7</subscript> -T <subscript>1</subscript> ) of the cardioaccelerator sympathetic outflow or for intravenous (i.v.) bolus injections of noradrenaline. Both procedures produced tachycardic responses remaining unaltered after saline. Continuous i.v. infusions of 5-HT induced a cardiac sympatho-inhibition that was mimicked by the 5-HT receptor agonists 5-carboxamidotryptamine (5-CT; 5-HT <subscript>1/5A</subscript> ), CP 93,129 (5-HT <subscript>1B</subscript> ), or PNU 142633 (5-HT <subscript>1D</subscript> ), but not by indorenate (5-HT <subscript>1A</subscript> ) in both groups; whereas LY344864 (5-HT <subscript>1F</subscript> ) mimicked 5-HT only in sarpogrelate-treated rats. In sarpogrelate-treated animals, i.v. GR 127935 (310 μg/kg; 5-HT <subscript>1B/1D/1F</subscript> receptor antagonist) attenuated 5-CT-induced sympatho-inhibition and abolished LY344864-induced sympatho-inhibition; while GR 127935 plus SB 699551 (1 mg/kg; 5-HT <subscript>5A</subscript> receptor antagonist) abolished 5-CT-induced inhibition. These results confirm the cardiac sympatho-inhibitory role of 5-HT <subscript>1B</subscript> , 5-HT <subscript>1D</subscript> , and 5-HT <subscript>5A</subscript> receptors in both groups; nevertheless, sarpogrelate treatment specifically unmasked a cardiac sympatho-inhibition mediated by 5-HT <subscript>1F</subscript> receptors.
- Subjects :
- Animals
Blood Pressure drug effects
Carbazoles pharmacology
Diastole drug effects
Electric Stimulation
Fluorobenzenes pharmacology
Heart Rate drug effects
Hemodynamics drug effects
Male
Norepinephrine pharmacology
Oxadiazoles pharmacology
Piperazines pharmacology
Rats, Wistar
Serotonin analogs & derivatives
Serotonin pharmacology
Serotonin Receptor Agonists pharmacology
Serotonin Receptor Agonists therapeutic use
Sodium Chloride pharmacology
Succinates pharmacology
Succinates therapeutic use
Sympathetic Nervous System drug effects
Sympathetic Nervous System physiopathology
Tachycardia drug therapy
Tachycardia physiopathology
Receptor, Serotonin, 5-HT1F
Myocardium metabolism
Receptors, Serotonin metabolism
Serotonin Antagonists pharmacology
Sympathetic Nervous System metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1205-7541
- Volume :
- 96
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Canadian journal of physiology and pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 28886249
- Full Text :
- https://doi.org/10.1139/cjpp-2017-0191